Member Info for lordloadsoflolly

For the time being at least, there seems to be some resistance in the £6-£7 area. Whilst non-one can tell, I personally doubt we've quite seen the bottom yet. And it's already gone a bit lower than I'd expected back in March (when I thought £8 or so would be the bottom). Barring some form of truce in Ukraine, winter '22 is likely to look pretty grim. As I've a significant holding here already, I'll mainly be aiming to trade in & out rapidly with any new funds over the summer & autumn. Hopefully by spring 23, the fog of war & inflation will be lifting slightly, giving a slightly clearer long term outlook.

Not sure why you keep trying to convince everyone of this. Almost like you're trying to reassure yourself. IF phase 3 is approved, then yes the share price will probably rise significantly short term. Though you could argue the current price factors in the likelihood of this anyway, so the rise might not be quite as exciting as you expect. But as I've repeatedly said, it's still an IF rather than a WHEN, which is why the share price currently remains below 6p.

toyin & cliostock - it seems the sun has got to you both. I'm now going outside to enjoy it, rather than waste any further time here. Enjoy paying to listen to people who've - so far - frequently called it wrong.

cliostock - "We all had an RNS, that’s the cheeseburger. Subscribers to Elric or TW got fries with it." All very well, but meat's got protein, whereas fries are unhealthy & fatty. You undermine your own argument by saying "There is no information revealed in the interviews that isn’t already in the public domain, or couldn’t be asked to the company by any investor." If that's the case, why waste £35 on a subscription to someone who has skin in the game (no pun intended) and is therefore far from neutral?

I've no view on price direction for SBTX. My only holding is indirect (via my Opti shares). But I do think ANY CEO who suggests their company's shares are a buy is both unprofessional & slightly desperate-sounding.

CaptainPicard - you're welcome! It wasn't really intended as reassurance though, as I've no idea how SMT will fare today, tomorrow or longer term. Nor does anyone else, even including the trust managers. All investors can do is look at long term performance - as well as previous bouts of volatility - then draw conclusions and either stick or sell. As I mentioned a few days ago, one other approach during exceptionally volatile periods is to trade a small part of your holding. I've been doing this, buying when all is doom & gloom in the wider markets, then selling a few days later to recoup whatever I originally spent (assuming the share price has risen in the meantime). Of course, this too carries risk as the price might move further against you. So you've got to be prepared to hold for longer (or sell at a loss) if things don't go to plan. If things do work out, I believe in taking a profit as soon as the price moves 10% or so in your favour, as it could easily drop back again a few days later. The aim of the exercise is not to make vast profits or even to maximise them necessarily. It's simply to recoup the amount you originally spent, adding some "free" shares to your holding that result from any positive price movement.

It's not "when FDA approval lands", it's "if". Whiltst looking more likely, it's still no racing certainty. Otherwise the share price wouldn't be where it is.

It's only ever a loss (or a profit) when you sell what you've bought. Paper profits & losses may make us feel good/bad, but they're really best ignored (unless you're about to sell).

thanks ukchips - hope it slipped down nicely. And that SMT's price doesn't follow suit for much longer.

dobbin46 - re: Q7 - in one of his podcasts, SOH did say he'd consider reverting to Aim if AQSE didn't work out, though I don't recall him giving any timescale. AQSE is clearly cheap for a reason (i.e. practically nobody uses it!).

Pour yourself a glass ukchips. Tomorrow (or rather Monday) is another day.

Always assuming the FDA grants approval of course. It's not a given. Otherwise the share price wouldn't be at its current level.

That's the conundrum in a nutshell really. Drip feed buy ins now, on the understanding SMT could go lower. Or wait & see, on the understanding you may miss the lows. One alternative I've done a bit of (given SMT's current volatility) is trading small portions of my holding. For instance, I bought £10K's worth at just below £7 on 25 May, before cashing out the same value 2 days later at a 10% premium. Result: my cash holding is unchanged, but I've added around 140 "free" SMT shares to my portfolio. Of course this too carries risk, as the price could move against you. So you need to be happy with whatever price you buy in at, in case you get lumbered for longer (or the price never recovers).

lambo222 - one thing that changes the potential upside dramatically v. previous phase 3 trial is US rights ownership. So I can't see anything like the same climb this time (though I agree it's likely to boost the share price from its current level - for a while at least).

ukchips - sorry you didn't secure that loan - most unreasonable of JB! To answer your question (even though it was rhetorical): Like the NASDAQ, SMT largely comprises growth stocks with huge potential. But also high risk. However, it hasn't mirrored the NASDAQ that closely over the past year (more's the pity for SMT holders!). Whilst the NASDAQ has fallen around 25% from just over 16,000 at peak last Nov to around 12,200 currently, SMT has almost halved over the same period from around 1540p to 800p. I guess SMT's unlisted securities have been partly to blame, as their valuations tend to lag - creating extra uncertainty. I'm not unduly worried at these levels though and suspect within 5 years things will be looking rosier again for BG & SMT.

denby69 - what drivel.

Angersharz - As I expect you well know, I wasn't pointing to RM's share price chart for future guidance. I simply meant it reflected how investors viewed RM's evolving fortunes in recent months. Here are the facts. They are NOT anecdotes. They are NOT my personal opinions. They are facts. On 31 Dec 2021, RM's closing price was 506p. Today, at the time of writing, it's toying with the 300p level. No amount of dividends, be they final, interim or special can plug anything like that sort of gap. I'm not saying now isn't a good time to invest (though I personally wouldn't buy above 250p unless the outcome of union negotiations was clearer, with greater visibility on this year's parcel volumes). But it's a fact that unless you bought in early Oct 21 and got out by mid Feb 22, this share has lost you a packet (and we're talking large parcel here). But you carry on convincing yourself otherwise if it makes you feel any better. I won't be back on this board for a while again now, as sadly the overwhelmingly positive bias makes it's a waste of time.

Yeah right. That's why it says "Price 1177.00" alongside your latest post. And has since gone up to close at 1184.00. You really don't appear to know even your basic ABC.

Thought the Scotch had got to you for a minute there, ukchips! I'm no booze expert, but never any harm in diversifying your investments to spread risk. That said, I wouldn't agree "all technology shares will simply track sideways for years now, the good times are over". Firstly, SMT isn't a tech share, nor are the majority of its holdings. Secondly, I'm not convinced inflation is here to stay, if by that you mean for the next 5 years. I agree though that shorter term (next 2 or so years ) inflation is baked in. But SMT should only be a long term investment anyhow.

Dynamofc - Look up analysis from Ofcom & Credit Suisse. AngerSharkz - not great news if RM's losing market share. But you carry on believing what you choose. I'm not invested here, so have nothing to lose. Just trying to give some real world data. And that suggests RM isn't in a great place right now. If you don't want to believe me, that's fine, Maybe try the share price graph instead.